baber/WOPTO huggingface dataset:
Patent IL-92912-A0 (IL)
Title: Heparinic derivatives and process for their preparation
IPC: C08B37/10
Filed: 1989-12-28
Abstract: New heparinic derivatives having anticalculous activity, devoid of the anticoagulant and antithrombotic activity characteristic of the heparins, obtained by treating commercial or purified or low molecular ueight heparins in a basic medium, optionally in the presence of alkali metal salts and of a reducing agent. The heparinic derivatives obtained through this treatment show peculiar chemical-physical characteristics, in particular they present a <1><3>C-NMR spectrum different from that of the starting haparins especially in the zone comprised between 102 and 92 p.p.m., with the presence of a characteristic signal at 101.3 p.p.m., a specific rotatory power at 546 nm comprised betueen about +15 DEG and about +40 DEG in aqueous solution, a sulfur content comprised between about 6% and about 9%, a sulfate/carboxyls ratio comprised between about 1.20 and about 1.70 and a content of free amino groups comprised between about 0.4% and about 2.1%. Said heparinic derivatives can be useful in the treatment of the nephrolithiases.
Patent IL-94774-A0 (IL)
Title: Microcapsules containing food additives and their use
IPC: A23L27/30
Filed: 1990-06-18
Abstract: The present invention provides a microcapsule for delivering a food additive to a food product to be baked or cooked. The microcapsule in accordance with the invention is particularly suitable for delivering such a food additive which is labile upon simultaneous exposure to water and temperatures such as are prevailing during the cooking or baking process. The microcapsule of the invention consists of a core and a coating, and comprises optionally also a leavening agent whereby the core comprises the food additive and the coating comprises either a hydrogenated castor oil (HCO) film or, where the microcapsule comprises also a leavening agent, a material which forms a water impermeable film which may be ruptured by gases formed by the leavening agent when the temperature is increased.
Patent IL-97714-A0 (IL)
Title: Inclusion complexes of n-ethoxycarbonyl-3-morpholino-sydnonimine or salts formed with cyclodextrin-derivatives,preparation thereof and pharmaceutical compositions containing the same
IPC: A61K31/41
Filed: 1991-03-28
Abstract: Clathrates (I) of N-ethoxycarbonyl-3- morpholino-sydnonimine (II) or its salts with cyclodextrin derivs. (III) are new. N.B., cpds. (III) include unsubstd. beta- and gamma-cyclodextrins. (II) is an anti-angina and anti-ischaemic agent (molsidomin) useful for prevention and treatment of angina pectoris. It also has antiarrhythmic, fibrinolytic, platelet aggregation inhibitory and hypotensive activity. Pref. (III) are selected from beta-cyclodextrin (BCD), gamma-cyclodextrin, heptakis-2,6,O-dimethyl -beta-cyclodextrin and hydroxypropyl- beta-cyclodextrin.
Patent SE-8401387-A0 (SE)
Title: System för att väcka uppmärksamheten hos syn- eller hörselskadade personer eller personer i bullrig miljö
Inventor: BENGT OVELIUS
IPC: A61F11/04
Filed: 1984-03-13
Abstract: Ett system fOr att NY-data uppmgrksamheten hos syn- eller hOrselskadade personer eller personer i bullrig miljO innefattar en sandare (2) som gr aktiverbar av signalen fran en dorrklocka (4), telefon (6) eller dylikt eller av ett sgrskilt anrop. Sandaren sander harvid tradlOst en signal till en av personen buren mottagarenhet (8), som till svar pa mottagen signal aktiverar en anordning fdr alstring av fysisk retning pa personen. Fig. 1.
Patent FI-20022069-A0 (FI)
Inventor: FREDRIKSON MARTTI
IPC: C10L1/18
Filed: 2002-11-20
Abstract: The invention relates to a method for manufacturing a lubricant additive to fuel, using fatty-acid compounds. In the method, saturated fatty acids, which are esterified and possibly aminated, with a high melting point are separated from a fatty-acid mixture by cooling, the mixture thus obtained being mixed again with the part of the original fatty-acid mixture from which the fatty acids with a high melting point have been separated, the necessary amount of this latter mixture being mixed with fuel as a lubricant. The fatty-acid mixture is separated in the presence of a solvent or solvent mixture containing alcohol groups and the solvent or solvent mixture are used to esterify the removed fatty acids. The said solvents are removed from the mother liquor and the esterified fractions are combined with the residue of the mother liquor and used as an auxiliary agent in fuel.
Patent IL-100872-A0 (IL)
Title: Preparation of purified alkanesulfonic acid
IPC: C07C309/04
Filed: 1992-02-05
Abstract: A process of preparing purified alkanesulfonic acid from crude aqueous alkanesulfonic acid containing oxidizable impurities wherein the crude material is treated with a sufficient amount of chlorine to convert the oxidizable impurities to alkanesulfonyl chloride and then hydrolyzing said alkanesulfonyl chloride to alkanesulfonic acid by heating.
Patent IL-101540-A0 (IL)
Title: Method and composition for the treatment of herpes related disorders
IPC: A61P31/12
Filed: 1992-04-09
Abstract: A method and composition are provided for treatment of herpes virus infections. The invention comprises the administration of a low level of neuraminidase protein or a derivative thereof.
Patent IL-103028-A0 (IL)
Title: Method and apparatus for using hazardous waste to form non-hazardous aggregate
IPC: B01D53/50
Filed: 1992-09-02
Abstract: Apparatus for converting hazardous waste into non-hazardous, non-leaching aggregate comprises means (10) for burning the hazardous waste to produce particulate solid materials, volatile gases and gaseous combustion by-products, oxidising means comprising at least one refractory-lined water-cooled, metal-walled vessel (26), means (76) for introducing the particulate solid materials, volatile gases and gaseous combustion by-products into the oxidising means (26), means (36,38) for inducing combustion in the oxidising means (26), the heat of combustion forming molten slag and non-combustible fines from non-combustible material. The slag (40) is accumulated at the bottom of the oxidising means (26). The non-combustible fines are accumulated in an accumulator (84) and introduced through conduits (102,103,105) into the molten slag to form a substantially molten mixture. An injector (117) is arranged to inject the non-combustible fines into the molten slag beneath its surface. The molten mixture is then removed into a slag box (108) and is cooled by cooling means (106) to form the non-hazardous aggregate.
Patent IL-104111-A0 (IL)
Title: Microbial process for the production of trans-4-hydroxy-l-proline
IPC: C12P13/24
Filed: 1992-12-16
Abstract: Trans-4-hydroxy-L-proline is produced microbially, especially by the cultivation of a microorganism of the genus Clonostachys, Gliocladium or Nectria.
Patent IL-111010-A0 (IL)
Title: A hydraulic valve
IPC: E03D1/32
Filed: 1994-09-19
Abstract: The present invention discloses a valve which utilises an imbalance of flow induced pressure forces to keep the valve open or closed. The valve has an interior cavity (15) into which an opposite and aligned inlet (12) and outlet (13) open. A bulbous body (16) is located within the cavity and is reciprocally mounted on a spindle (17) which passes through the outlet. Movement of the body increases the flow area at one end of the body and decreases the flow area at the other end of the body. In accordance with Bernoulli's theory this changes the pressures acting on the body (16) giving rise to a net force on the body. A cistern inlet valve (111, 211) and cistern (19) are also disclosed. <IMAGE>
Patent IL-111977-A0 (IL)
Title: Ultrasound contrast media, contrast agents containing the media and method
IPC: A61K49/18
Filed: 1994-12-14
Abstract: The invention relates to injectable media for ultrasonic echography in the form of microbubbles or microballoons comprising at least two biocompatible substances A and B (gaseous at the body temperature) forming a mixture which when in suspension with usual surfactants, additives and stabilisers provides useful ultrasound contrast agents. At least one of the components (B) in the mixture is a gas whose molecular weight is greater than 80 daltons and whose solubility in water is below 0.0283 ml per ml of water at standard conditions. The presence of the first component (B) in the contrast medium may vary between 0.5 and 41 volume percent. The other component (A) of the ultrasound contrast media is a gas or a mixture of gases whose molecular weight is below 80 daltons. The second component is present in a proportion of between 59-99.5% by vol., and is preferably chosen from oxygen, air, nitrogen, carbon dioxide or mixtures thereof. Gas mixtures described are found to be very effective as ultrasound contrast media. The invention also comprises a method of making the ultrasound contrast medium, the contrast agent and the ultrasound agent kit.
Patent IL-114241-A0 (IL)
Title: Thiazolidine derivatives their preparation and compositions containing them
IPC: A61P27/02
Filed: 1995-06-20
Abstract: PCT No. PCT/FR95/00808 Sec. 371 Date Dec. 19, 1996 Sec. 102(e) Date Dec. 19, 1996 PCT Filed Jun. 19, 1995 PCT Pub. No. WO95/35314 PCT Pub. Date Dec. 28, 1995Thiazolidine derivatives of formula (I), in which R1, R2, R3, R4 and R5 are as defined in the specification. The invention also concerns the salts of these derivatives, the preparation thereof and drugs containing same.    <IMAGE>  (I)
Patent IL-115873-A0 (IL)
Title: Transgenic protein production
IPC: C12N15/85
Filed: 1995-11-03
Abstract: DNA hybrid construct for efficient targeting expression of a protein in the mammary glands of a transgenic animal, with limited ectopic expression in other tissues. A transgenic mammal is disclosed which has a  beta -lactoglobulin (BLG)/human serum albumin (HSA) cDNA hybrid construct incorporated in its genome. The BLG construct is comprised of BLG 5'-flanking sequences (e.g. promoter) and BLG intragenic sequences in conjunction with a desired cDNA such of HSA, or a minigene (coding sequences and less than all intron sequences) or a gene (coding sequences and all intron sequences) assembled for the purpose of targeting expression of the product of the encoding "DNA". <IMAGE>
Patent IL-118226-A0 (IL)
Title: Variable focus lens by small changes of the equatorial lens diameter
IPC: G03F7/20
Filed: 1996-05-12
Abstract: A variable focus lens is constructed by making small changes in the equatorial diameter of an elastically deformable lens. The lens may be deformed by radial tension exerted in a plane generally perpendicular to the optical axis. The radial tension may be exerted by radially acting mechanical apparatus or by means of rings embedded or attached at the equator of the lens, whose diameter can be altered by heating, or by imposition of electrical or magnetic fields.
Patent IL-131023-A0 (IL)
Title: Improved missile warhead design with a window having a conicoidal inner surface and testing of the improved missile warhead design
IPC: F42B12/20
Filed: 1998-12-03
Abstract: A hard-target penetrating warhead (10) adapted for use with length constrained warhead payload bays. The warhead (10) includes a warhead case (12) for containing warhead explosives (22, 27). A tungsten ballast (16) is disposed within the case (12) for providing a high warhead sectional pressure upon impact of the warhead (10) on a target. A fuse (19) detonates the warhead explosives (22, 27) upon penetration of the target. The fuse (19) is housed by a fuse well (18) that is attached to the case (12) at one end. A slip fit section of the fuse well (18) provides structural support to the case (12) and prevents dislodging of the fuse well (18) and the fuse (19) from the case (12) upon warhead target impact. Explosives blowout ports (24) included in the fuse well (18) inhibit undesirable explosion or detonation of the warhead explosives (22, 27) by accidental exposure to high heat or fire. In a specific embodiment, the case (12) has a 6 caliber radius head nose (14). The explosives blowout ports (24) include main explosives blowout ports (24) for allowing the heat to burn the warhead explosives (22) and vent gases resulting from the burning. The main explosive blowout ports (24, 25) are placed around a circumference of the fuse well (18) and include nine ports having a surface area designed to minimize danger of explosion and/or detonation in the event of an accidental fire. The blowout ports (24, 25) also include booster blowout ports (25) for allowing safe burning of booster charge explosives (27) included in the fuse (19). Additionally, a special polyethelene/polyalphaolefin liner (20) lines the inside of the case (12) and improves fast cook-off safety performance. In the illustrative embodiment, the warhead explosives (22) include PBXN-109. The case (12) includes a textured or grooved surface that facilitates bonding of the ballast (16) to the case (12).
Patent IL-135044-A0 (IL)
Title: Cache memory operation
IPC: G06F12/0888
Filed: 1998-11-11
Abstract: A cache controller is disclosed that includes a first means for determining when data specified by a memory address requested by the processor is absent from the cache, and a second means for determining when the processor reads sequential memory addresses. The second means is activated when the first means detects that data is absent from the cache and causes the cache controller to (i) permit data to be supplied from the main memory to the processor, even when the data is available in the cache; (ii) inhibit the first means from determining whether requested data is available in the cache; and (iii) update the cache with data supplied to the processor from the main memory.
Patent IL-139108-A0 (IL)
Title: Solar cell panel and solar energy collecting device
IPC: F24S10/75
Filed: 1999-04-13
Abstract: The invention concerns a panel comprising a front plate exposed to solar radiation and whereof the rear face is adjacent to an insulating layer, for example made of a synthetic foam. A conduit network for heat transferring fluid is inserted between the front plate and the insulating layer. A conducting lap such a fine and flexible aluminum grille is also inserted between the front plate and the heat insulating layer to collect the heat generated in the front plate and conduct it towards the conduit network. The invention is useful for collecting solar energy in the form of heat particularly in roofs.
Patent IL-145112-A0 (IL)
Title: Kits and methods for radiolabeling proteins and peptides
IPC: C07B59/00
Filed: 2000-02-29
Abstract: Methods and kits for radiolabeling proteins and peptides with radiolytic isotopes, particularly yttrium-90, are disclosed, whereby sufficient purity, specific activity and binding affinity are achieved such that the radiolabeled protein may be directly administered to a patient without further column purification. Such kits and methods will be particularly useful in bringing radioimmunotherapy to the hospital and outpatient setting for the treatment of cancer.
Patent IL-160272-A0 (IL)
Title: Pharmaceutical compositions containing a pde4 or a pde3/4 inhibitor and a leukotriene receptor antagonist
IPC: A61K31/47
Filed: 2002-09-17
Abstract: The invention relates to the combined administration of PDE4 or PDE3/4 inhibitors and leukotriene receptor antagonists for the treatment of respiratory tract disorders.
Patent IL-165089-A0 (IL)
Title: Modified pigments, processes for preparing modified pigments and ink compositions containing them
IPC: B41J2/01
Filed: 2004-11-08
Abstract: Processes for preparing modified pigments are described. In one embodiment, the process comprises the step of combining, in any order, a pigment having attached an electrophilic group and a thiol reagent comprising at least one -SH group and at least two ionic or ionizable groups. In a second embodiment, the process comprises the step of combining, in any order, a pigment having attached an electrophilic group and a thiopolymer comprising at least one -H group. Modified pigments are also described.
Patent IL-178947-A0 (IL)
Title: Underwater lighting
IPC: F21V31/04
Filed: 2006-10-31
Abstract: An underwater lighting unit ( 1 ) for marine or other underwater use incorporates LEDs ( 13 ) as the light source and provides an array of LEDs ( 13 ) mounted against the back wall ( 11 ) of a metal or thermally conductive plastic housing ( 10 ) which utilizes the cooling effect of direct contact between the water and the housing to dissipate the heat generated by the LEDs ( 13 ) in use. The LEDs ( 13 ) each have an associated collimator ( 20 ) protected from contact with the water in which the unit ( 1 ) is to be immersed by a sealed glass screen ( 22 ), and each LED may be from one to three watts or more in power. There may be 30 or more LEDs ( 13 ) and associated collimators ( 20 ) in each lighting unit ( 1 ). The lighting unit ( 1 ) may be mounted in a cofferdam ( 2 ) of a marine vessel, directly against or slightly forwardly of the back wall of the cofferdam, or may be surface-mounted on the hull ( 3 ) of the vessel directly against or slightly spaced from the hull ( 3 ) and below the waterline.
Patent IL-184795-A0 (IL)
Title: Nucleic acids encoding a g-protein coupled receptor involved in sensory transduction
IPC: C12P/
Filed: 2007-07-23
Abstract: The invention provides isolated nucleic acid and amino acid sequences of sensory cell specific G-protein coupled receptors, antibodies to such receptors, methods of detecting such nucleic acids and receptors, and methods of screening for modulators of sensory cell specific G-protein coupled receptors.
Patent IL-198737-A0 (IL)
Title: Method for the adapting controller parameters of a drive to different operating states
Filed: 2009-05-14
Abstract: A method is provided for adapting controller parameters of a drive to different operating states. A control loop includes a PID controller whose I gain factor is adapted to a drive velocity and/or whose D gain factor is adapted to a drive current, and consequently to a drive load. The I gain factor is determined based on the drive velocity and the D gain factor is determined based on the drive current, in each case at least in one area, the I gain factor falling with the drive velocity and the D gain factor rising with the drive current.
Patent RO-127492-A0 (RO)
Title: Bioprotective nutraceutical products and process for preparing the same by fractioning food and therapeutical macromycetes
Inventor: ŢULUCA ELISAVETA VALERIA
IPC: A23L1/28
Filed: 2011-08-10
Abstract: The invention relates to macromycete-based bioprotective products to be employed as functional supplements and/or energizing stimulants and to processes for preparing the same. According to the invention, the products are presented as powder having a particle size in the range of 15...40 μ m, an average content of dry substance of 90...94%, 10...78% raw protein, 0.2...1.8% phenols, 1.2...1.8% raw ash. The processes claimed by the invention consist in stage fractioning macromycetes having a humidity of at least 75% in solvents of differentiated polarity, wherefrom there results bioprotective products to be used as components of food supplements and/or energizing or neuronal stimulants.
Patent RO-135571-A0 (RO)
Title: Apparatus for physiological stimulation
Inventor: TRUŞCULESCU NELUŢA
IPC: A61N1/02
Filed: 2021-06-22
Abstract: The invention relates to an apparatus for non-contact physiological stimulation by bioresonance. According to the invention, the apparatus comprises: a power supply circuit (101), a programmable signal generator (102), which generates sinusoidal or rectangular voltage electrical signals with an adjustable frequency between 0.4 Hz and 100MHz, with a 50% pulse duty factor and with an amplitude in the range of hundreds of millivolts, a quartz crystal (103), a circuit (104) for cleaning the crystal (103) consisting of a final current control stage (104a) and a pair of LEDs (104b, 104c), a circuit (105) for stimulating the crystal (103) which, in its turn, is composed of a final current control stage (105a) and a pair of stimulation LEDs (105b, 105c) and a control circuit (106) which, when power-supplied, controls the signal generator (102) and adjusts the frequency and waveform of the generated signal and controls the two final control stages (104a, 105a) so that one of the pairs of cleaning or stimulating LEDs (104b, 104c; 105b, 105c), respectively, are modulated in current to produce a luminous flux of the same waveform as the signal generator (102) and which varies in a pulsating manner between zero and a maximum configurable value, with distortions below 1%.
Patent ZW-9283-A1 (ZW)
Title: 1-sulfo-2-azetidinone derivatives their production and use
Inventor: KISHIMOTO SHOJI
IPC: A61P31/04
Filed: 1983-04-22
Abstract: A 1-sulfo-2-oxoazetidine derivative of the formula <CHEM> wherein R<a> is -COQ<0> (Q<0> is an amino group which may optionally be protected or substituted), -COQ<5> (Q<5> is a hydroxyl group which may optionally be protected), -(CH2)na- R<4a> (n<a> is an integer of 1 to 3; R<4a> is a hydrogen atom or a carbamoylamino, N-sulfocarbamoylamino, carbamoyl, carbamoyloxy, N-sulfocarbamoyloxy, haloalkylcarbonylcarbamoyloxy, alkylsulfonyloxy, pyridinio, alkoxy, alkylsulfinyl, alkylsulfonyl, halogenoalkylcarbonyloxy, hydroxyl, alkoxycarbonyl, acyloxy, 1-alkoxyiminoalkyl, alkylcarbony or acylamino group) or a nitrogen-containing heterocyclic group; R<1> is an amino group which may optionally be acylated or protected; and X is a hydrogen atom or a methoxy group, or a salt or ester thereof, and methods of producing said compound (I<a>) which may be shown as follows <CHEM> wherein the symbols have the same meanings as respectively defined above, and intermediates for preparing the compound (I<a>) and methods of producing them. The compound (I<a>) has improved antimicrobial and  beta -lactamase-inhibitory activities and is of value as drugs for human beings and domesticated animals.
Patent IE-910126-A1 (IE)
Title: Di(nitroxyalkyl)amides of pyridine-2,4- and¹-2,5-dicarboxylic acids, a process for the preparation¹thereof, and the use thereof
IPC: A61K31/4402
Filed: 1991-01-15
Abstract: The invention relates to pyridine-2,4- and -2,5-dicarboxydi(nitroxyalkyl)amides of the formula I  in which R has the meanings indicated. The compounds according to the invention inhibit the enzymes proline hydroxylase and lysine hydroxylase and can therefore be employed as fibrosuppressants and immunosuppressants.
Patent IE-910317-A1 (IE)
Title: Topical preparations for treating human nails
IPC: A61K31/195
Filed: 1991-01-30
Abstract: The use of sulphur containing amino acids as represented by the general formula wherein n = 1-4 R = H, alkyl having 1-12 C atoms, or carboxylic acyl, or pharmaceutically acceptable salts thereof, in particular N-acetyl-cysteine (NAC), for the preparation of topical compositions for the medical or cosmetic treatment of human nails. The topical compositions containing these compounds may be applied to the nails separately from or in combination with topically effective medicaments.
Patent LU-79090-A1 (LU)
Inventor: RAMEL A
IPC: A61P37/00
Filed: 1978-02-20
Abstract: RAN 4090/93 A solid stable endotoxin and pyrogen free form of thymosin fraction 5 preparation containing (a)  a major amount of thymosin fraction and minor, effective amounts each of (b)  a phenolic type antimicrobial agent, and (c)  a buffering agent in an amount sufficient to provide a pH of 7-8 on reconstitution and method for preparing same which method comprises (a)  ultrafiltering an aqueous solution of thymosin fraction 5 buffered with a volatile weakly basic buffer to a pH of 7 to 8 through a membrane having a molecular weight cut off of about 10,000, (b)  adding a phenolic type antimicrobial agent to the permeate and a buffering agent in anmount sufficient to provide of pH of 7-8 on reconstitution and (c)  lyophilizing the permeate.
Patent LU-86654-A1 (LU)
Inventor: BRUDER-HEID GERDA
IPC: G01N33/68
Filed: 1986-11-10
Abstract: To locate pathological centres in living organisms, the associated antibodies generated by the cytoskeletal proteins entering the serum are immunologically identified and quantified.